Skin Concern Severity Dosage depends on the extent of pigmentation, dullness, or oxidative damage affecting the skin
Given CJC-1295s status as a research chemical, any claims about this peptide's purported benefits have not been confirmed by human clinical trials and any statements online have not been evaluated by the FDA
2024;327(1):E1-E12
23,24 Age-Related Macular Degeneration Nonexudative age-related macular degeneration (AMD) is a complex and multifaceted disease caused by inflammation, lipid deposition, and oxidative stress, leading to drusen deposition and retinal pigment epithelium (RPE) damage
Presented for research literature review only Janky R et al
Within 5-10 years, the GLP-1 therapy landscape will likely include multiple oral options at various price points, fundamentally changing how metabolic disease is managed in primary care